JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259110

Human SHC2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SHC2 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon6 and 7 bp deletion in exon6.
2 Images
Sanger Sequencing - Human SHC2 knockout HeLa cell lysate (AB259110)
  • Sanger seq

Unknown

Sanger Sequencing - Human SHC2 knockout HeLa cell lysate (AB259110)

Allele-1 : 7 bp deletion in exon6

Sanger Sequencing - Human SHC2 knockout HeLa cell lysate (AB259110)
  • Sanger seq

Unknown

Sanger Sequencing - Human SHC2 knockout HeLa cell lysate (AB259110)

Allele-2 : 1 bp insertion in exon6

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon6 and 7 bp deletion in exon6.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259110-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SHC2 knockout HeLa cell lysate", "number":"AB259110-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259110-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SHC2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SHC2—also known as SHC transforming protein 2 or Src homology 2 domain-containing—functions as an adaptor protein involved in intracellular signal transduction. It has a molecular mass of approximately 64 kDa. SHC2 mainly gets expressed in the nervous system and tissues where it contributes to cellular differentiation and growth activities. Its expression level may vary depending on the cell type and developmental stage.
Biological function summary

SHC2 plays significant roles in the regulation of signal transduction pathways that control cell growth apoptosis and differentiation. It participates in the formation of complexes that relay signals from activated receptor tyrosine kinases. SHC2 by binding to these receptors through its SH2 domain helps in the recruitment of downstream signaling molecules like GRB2 leading to the activation of signaling cascades.

Pathways

SHC2 is critically involved in the MAPK/ERK signaling pathway which transmits signals from the cell surface to the DNA in the cell nucleus. This pathway's activation ultimately leads to cell growth and differentiation processes. SHC2 interacts with proteins such as GRB2 and SOS fostering signal transduction that is essential for maintaining proper cellular functions.

SHC2 has been associated with neurodegenerative disorders and certain types of cancer. Alterations in its expression or function can affect cell signaling leading to neural developmental disorders or contributing to tumorigenesis. For example its interaction with receptor tyrosine kinases can modulate pathways involved in cell proliferation connecting SHC2 to cancers where these receptors play a role in the disease's progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com